Secondary placing of 1.45 million shares in Medivir (SE) — SEK 197.2 million

Carnegie acted as sole book-runner in the secondary placing of 1.45 million shares in Medivir, at a price of SEK 136 per share. Medivir is an emerging research-based specialty pharmaceutical company focused on the development of high-value treatments for infectious diseases.March, 2011.